BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33867178)

  • 1. Autoantibody profiles in patients' sera associated with distribution patterns of dermatomyositis skin symptoms.
    Ogawa-Momohara M; Kinoshita F; Muro Y; Kobayashi Y; Takeichi T; Akiyama M
    J Am Acad Dermatol; 2021 Jun; 84(6):1720-1722. PubMed ID: 33867178
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.
    Tartar DM; Chung L; Fiorentino DF
    Clin Dermatol; 2018; 36(4):508-524. PubMed ID: 30047434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatomyositis: new antibody, new classification].
    Bolko L; Gitiaux C; Allenbach Y
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():18-23. PubMed ID: 31859626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
    Wolstencroft PW; Casciola-Rosen L; Fiorentino DF
    JAMA Dermatol; 2018 Oct; 154(10):1199-1203. PubMed ID: 30140893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort.
    Ueda-Hayakawa I; Fujimoto M; Sato S; Murakami A; Kawakami A; Mishima M; Seishima M; Suda T; Takehara K; Mimori T; Kuwana M
    J Dermatol Sci; 2021 Jul; 103(1):53-56. PubMed ID: 34088590
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
    Wolstencroft PW; Fiorentino DF
    Curr Rheumatol Rep; 2018 Apr; 20(5):28. PubMed ID: 29637414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India.
    Hussain A; Rawat A; Jindal AK; Gupta A; Singh S
    Rheumatol Int; 2017 May; 37(5):807-812. PubMed ID: 28331982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dermatomyositis and Autoantibodies].
    Fujimoto M
    Brain Nerve; 2018 Apr; 70(4):427-438. PubMed ID: 29632290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of Autoantibodies in Juvenile Dermatomyositis.
    Kwiatkowska D; Reich A
    Biomed Res Int; 2021; 2021():5513544. PubMed ID: 34840975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients.
    Best M; Jachiet M; Molinari N; Manna F; Girard C; Pallure V; Cosnes A; Lipsker D; Hubiche T; Schmutz JL; Le Corre Y; Cordel N; Dandurand M; Dereure O; Guillot B; Du-Thanh A; Bulai Livideanu C; Chasset F; Bouaziz JD; Francès C; Bengoufa D; Vincent T; Bessis D;
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1164-1172. PubMed ID: 29237090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
    Kishaba T; McGill R; Nei Y; Ibuki S; Momose M; Nishiyama K; Nagano H; Yamashiro S
    J Med Invest; 2018; 65(3.4):251-257. PubMed ID: 30282869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MDA5-Positive Dermatomyositis: A Description of the Cutaneous and Systemic Manifestations in 2 Cases.
    Barrientos N; Sicilia JJ; Moreno de Vega MJ; Dominguez JD
    Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):188-190. PubMed ID: 29162227
    [No Abstract]   [Full Text] [Related]  

  • 14. Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis.
    Combalia A; Giavedoni P; Tamez L; Grau-Junyent JM; Mascaró JM
    JAMA Dermatol; 2018 Mar; 154(3):371-373. PubMed ID: 29344607
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups.
    Nguyen M; Do V; Yell PC; Jo C; Liu J; Burns DK; Wright T; Cai C
    Acta Neuropathol Commun; 2020 Aug; 8(1):125. PubMed ID: 32758284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy.
    Monseau G; Landon-Cardinal O; Stenzel W; Schoindre Y; Mariampillai K; Barete S; Martel C; Masseau A; Meyer A; Terrier B; Guégan S; Verneuil L; Audia S; Livideanu CB; Hachulla E; Kahn JE; Lefevre G; Maurier F; Moulis G; Papo T; Dossier A; Descamps V; Salort-Campana E; Richard MA; Bergot E; Mortier L; Costedoat-Chalumeau N; Genot S; Perez F; Piette AM; Samson M; Schleinitz N; Zénone T; Lacoste M; de Boysson H; Madaule S; Rigolet A; Champtiaux N; Hervier B; Bouvier AM; Jooste V; Léonard-Louis S; Maisonobe T; Aouba A; Benveniste O; Bienvenu B; Allenbach Y;
    J Am Acad Dermatol; 2020 Dec; 83(6):1759-1763. PubMed ID: 32244015
    [No Abstract]   [Full Text] [Related]  

  • 18. Myositis autoantibodies.
    Casciola-Rosen L; Mammen AL
    Curr Opin Rheumatol; 2012 Nov; 24(6):602-8. PubMed ID: 22955022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.